J
Jenny L Donovan
Researcher at University of Bristol
Publications - 586
Citations - 44316
Jenny L Donovan is an academic researcher from University of Bristol. The author has contributed to research in topics: Prostate cancer & Randomized controlled trial. The author has an hindex of 100, co-authored 562 publications receiving 39131 citations. Previous affiliations of Jenny L Donovan include University of Tampere & Southmead Hospital.
Papers
More filters
Journal Article
Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis
Nora Pashayan,Stephen W. Duffy,David E. Neal,Freddie C. Hamdy,Jenny L Donovan,Richard M. Martin,Patricia Harrington,Sara Benlloch,Ali Amin Al Olama,Mitul Shah,Zsofia Kote-Jarai,Douglas F. Easton,Rosalind A. Eeles,Paul D.P. Pharoah +13 more
TL;DR: In this article, the probability of overdiagnosis of prostate cancer by polygenic risk was quantified by quantifying the probability that a man will be diagnosed with prostate cancer overdiagnosed.
Journal ArticleDOI
Suicide communication events: Lay interpretation of the communication of suicidal ideation and intent
TL;DR: It is concluded that better understanding of how suicide communication events occur and the challenges they pose for significant others may provide a basis for strengthening public involvement in suicide prevention.
Journal ArticleDOI
Relationship between lower urinary tract symptoms and erectile dysfunction: results from the Boston Area Community Health Survey.
TL;DR: Evidence is provided to suggest that the previously observed association between erectile dysfunction and lower urinary tract symptoms may be primarily due to nocturia, incontinence and symptoms suggestive of prostatitis.
Journal ArticleDOI
Secular trends in prostate cancer mortality, incidence and treatment: England and Wales, 1975-2004
Sabina Hussain,David Gunnell,Jenny L Donovan,Sean McPhail,Freddie C. Hamdy,David E. Neal,Peter C. Albertsen,Julia Verne,Peter Stephens,Caroline Trotter,Richard M. Martin +10 more
TL;DR: To aid the interpretation of the trends in prostate cancer mortality, which declined in the UK in the early 1990s for unknown reasons, by investigating prostate cancer death rates, incidence and treatments in England and Wales in 1975–2004.
Journal ArticleDOI
Genetic variants in the vitamin d receptor are associated with advanced prostate cancer at diagnosis: findings from the prostate testing for cancer and treatment study and a systematic review
Lina Chen,George Davey Smith,David M. Evans,Angela Cox,Debbie A Lawlor,Jenny L Donovan,Wei Yuan,Ian N.M. Day,Richard M. Martin,Athene Lane,Santi Rodriguez,Michael Davis,Luisa Zuccolo,Simon M Collin,Freddie C. Hamdy,David E. Neal,Sarah J Lewis +16 more
TL;DR: Genotyping five well-known VDR polymorphisms in 1,604 men with prostate cancer from the Prostate Testing for Cancer and Treatment study revealed three polymorphisms, BsmI, ApaI, and TaqI, associated with high Gleason score, providing some support for the hypothesis that low levels of vitamin D may increase the risk of prostate cancer progression.